Advertise With UsAdvertise on our extensive network of industry websites and newsletters.
Get the PBR newsletterSign up to our free email to get all the latest PBR
news.Company to lead collaborative research and development project with the team at the University of Saarland
Subscribe to our email newsletter
InterMed Discovery (IMD) has reported the acquisition of microbial Omega-3 fatty acid production strains and related know-how from the University of Saarland.
Reportedly, the microbial source has the potential to produce Omega-3 more sustainably and reliably, compared to established sources.
The company said that the microbial strains acquired are sustainable sources that generate reliably high yields of Omega-3 fatty acids, which significantly out-perform current sources. This source also offers a more favourable ratio between the fatty acids, DHA and EPA.
IMD will lead the collaborative research and development project with the team at the University of Saarland.
Bernard Becker, managing director of InterMed Discovery, said: “These microbial strains offer not only a new sustainable and reliable source of Omega-3, but also give us the capability to develop products with outstanding quality at competitive pricing.”